相似文献
1
Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.
Eur J Rheumatol. 2018 Mar;5(1):53-57. doi: 10.5152/eurjrheum.2017.16116. Epub 2017 Aug 29.
2
Management of calcium pyrophosphate crystal deposition disease: A systematic review.
Semin Arthritis Rheum. 2021 Feb;51(1):84-94. doi: 10.1016/j.semarthrit.2020.10.005. Epub 2020 Dec 21.
3
Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
J Rheumatol. 2023 Aug;50(8):1058-1062. doi: 10.3899/jrheum.2023-0031. Epub 2023 Apr 15.
4
Calcium Pyrophosphate Crystal Deposition: Insights to Risks Factors and Associated Conditions.
Curr Rheumatol Rep. 2024 Nov;26(11):375-382. doi: 10.1007/s11926-024-01158-5. Epub 2024 Aug 5.
5
Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
Semin Arthritis Rheum. 2021 Aug;51(4):946-950. doi: 10.1016/j.semarthrit.2021.04.019. Epub 2021 Jun 14.
6
Bartter's syndrome and chondrocalcinosis: a possible role for hypomagnesemia in the deposition of calcium pyrophosphate dihydrate (CPPD) crystals.
Clin Exp Rheumatol. 1989 Jul-Aug;7(4):415-20.
7
Calcium Pyrophosphate Dihydrate Deposition Disease in Young Patients: Two Case Reports.
Arch Rheumatol. 2016 Dec 8;32(1):80-83. doi: 10.5606/ArchRheumatol.2017.6015. eCollection 2017 Mar.
9
Calcium pyrophosphate deposition (CPPD) in a liver transplant patient: are hypomagnesemia, tacrolimus or both guilty? A case-based literature review.
Rheumatol Int. 2022 Jun;42(6):1105-1112. doi: 10.1007/s00296-021-04828-0. Epub 2021 Mar 11.
10
Pathogenesis of calcium pyrophosphate deposition disease.
Best Pract Res Clin Rheumatol. 2021 Dec;35(4):101718. doi: 10.1016/j.berh.2021.101718. Epub 2021 Oct 22.
引用本文的文献
1
Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes.
Int J Mol Sci. 2022 Feb 26;23(5):2604. doi: 10.3390/ijms23052604.
2
A Case of Extensive Bilateral Idiopathic Sclerochoroidal Calcification and Review of Literature.
Int Med Case Rep J. 2021 Oct 28;14:749-755. doi: 10.2147/IMCRJ.S336237. eCollection 2021.
3
The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.
Mol Biol Rep. 2021 May;48(5):4789-4796. doi: 10.1007/s11033-021-06457-z. Epub 2021 Jun 1.
4
[Chondrocalcinosis: idiopathic or manifestation of rare metabolic diseases?].
Orthopade. 2019 Nov;48(11):949-956. doi: 10.1007/s00132-019-03805-7.
本文引用的文献
1
Effect of parathyroid hormone on serum magnesium levels: the neglected relationship in hemodialysis patients with secondary hyperparathyroidism.
Ren Fail. 2016;38(1):50-6. doi: 10.3109/0886022X.2015.1106847. Epub 2015 Dec 16.
2
Chondrocalcinosis related to familial hypomagnesemia with hypercalciuria and nephrocalcinosis.
J Pediatr Endocrinol Metab. 2015 May;28(5-6):713-6. doi: 10.1515/jpem-2013-0254.
3
Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial.
Arthritis Res Ther. 2014 Oct 15;16(5):458. doi: 10.1186/s13075-014-0458-4.
4
Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
Joint Bone Spine. 2013 Mar;80(2):178-82. doi: 10.1016/j.jbspin.2012.07.018. Epub 2012 Sep 28.
5
Chronic calcium pyrophosphate crystal inflammatory arthritis induced by extreme hypomagnesemia in short bowel syndrome.
BMC Gastroenterol. 2012 Sep 22;12:129. doi: 10.1186/1471-230X-12-129.
6
[Chondrocalcinosis and hypomagnesemia: clinical and radiological progression].
Reumatol Clin. 2008 Jan;4(1):37-9. doi: 10.1016/S1699-258X(08)71794-7. Epub 2008 Oct 28.
7
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis.
Ann Rheum Dis. 2011 Apr;70(4):563-70. doi: 10.1136/ard.2010.139105. Epub 2011 Jan 7.
8
Pseudoneuropathic CPPD arthropathy: magnesium matters.
Rheumatology (Oxford). 2008 Apr;47(4):551-2. doi: 10.1093/rheumatology/ken016. Epub 2008 Feb 12.
9
Transcriptional and functional analyses of SLC12A3 mutations: new clues for the pathogenesis of Gitelman syndrome.
J Am Soc Nephrol. 2007 Apr;18(4):1271-83. doi: 10.1681/ASN.2006101095. Epub 2007 Feb 28.
10
Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.
Arthritis Rheum. 2007 Feb;56(2):688-92. doi: 10.1002/art.22389.
Zotero 插件